Skip to content

Insider · CIK 0001975263

Richard Alan Rudick

director

Files at IMUX (IMMUNIC, INC.). First filing Nov 13, 2024, latest Jun 4, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 1
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
2 / 0
$200k bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

IMUX: IMMUNIC, INC.

IMUXOct 9, 2026 · close 8.19

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
58Moderate
IMUXbuy 6
IMMUNIC, INC.
$100k
143,075 shares
+164%+11% from low-63% from high
33Weak
IMUXbuy
IMMUNIC, INC.
$100k
87,300 shares
--

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jun 5, 2025IMUX
IMMUNIC, INC.
AGrant or award
Stock Optionderivative
+150,000$0.00$0150,000Jun 9, 2025
Jun 3, 2025IMUX
IMMUNIC, INC.
POpen-market purchase
Common Stock
+143,075$0.70$100k230,375Jun 4, 2025
Nov 12, 2024IMUX
IMMUNIC, INC.
POpen-market purchase
Common Stock
+87,300$1.15$100k87,300Nov 13, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Richard Alan Rudick: insider trades and track record | InsiderTell